Cargando…
In vitro toxic evaluation of two gliptins and their main impurities of synthesis
BACKGROUND: The presence of impurities in some drugs may compromise the safety and efficacy of the patient’s treatment. Therefore, establishing of the biological safety of the impurities is essential. Diabetic patients are predisposed to tissue damage due to an increased oxidative stress process; an...
Autores principales: | Giordani, Camila F. A., Campanharo, Sarah, Wingert, Nathalie R., Bueno, Lívia M., Manoel, Joanna W., Costa, Barbara, Cattani, Shanda, Arbo, Marcelo Dutra, Garcia, Solange Cristina, Garcia, Cássia Virginia, Volpato, Nádia Maria, Schapoval, Elfrides Eva Scherman, Steppe, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921383/ https://www.ncbi.nlm.nih.gov/pubmed/31852534 http://dx.doi.org/10.1186/s40360-019-0354-2 |
Ejemplares similares
-
The application of quality by design in the development of the liquid chromatography method to determine empagliflozin in the presence of its organic impurities
por: Manoel, Joanna Wittckind, et al.
Publicado: (2020) -
Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
por: Heleno Ferreira, Raquel Balestri, et al.
Publicado: (2019) -
Choosing a Gliptin
por: Gupta, Vishal, et al.
Publicado: (2011) -
What the future holds for gliptins
por: Jindal, Radhika, et al.
Publicado: (2012) -
Prescribing gliptins: Enthusiasm should be coupled with caution
por: Garg, M. K., et al.
Publicado: (2012)